Company Profile
Charles River Stock Price, News & Analysis
- Ticker:
- CRL
- Exchange:
- NYSE
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NYSE, Charles River is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
186.60 USD (+2.78%)
Close
Last updated: June 23, 2026 at 00:00
8.99B USD
Market cap
Why the stock is moving
CRL is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Charles River is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Charles River is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Charles River follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Charles River sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Charles River Laboratories to Present at William Blair and Jefferies Conferences
Source: Charles River
- 03
- 04
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow
Source: Charles River
- 05
Charles River Laboratories Announces First-Quarter 2026 Results
Source: Charles River
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Charles River (CRL)?
Charles River (CRL) most recently closed at 186.60 USD, a +2.78% move versus the previous session.
What is the market cap of Charles River (CRL)?
Charles River currently has a market capitalization of 8.99B USD on BioPharmSignal.
What does Charles River do?
Charles River is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is CRL stock listed?
Charles River (CRL) is associated with NYSE, Headquartered in the United States and listed on NYSE, Charles River is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Charles?
Charles River is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Charles River targeting with Charles?
Charles River is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is River?
Charles River is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.